Editorial Board Members| Clyto Access

Editorial Board Members

Dr. Yoshitsugu Akiyama

Tokyo University of Science, Japan

Expertise: Biomaterials, Polymer synthesis, Bioorganic chemistry and Drug Delivery System

Dr. Yoshifumi Saisho

Keio University School of Medicine Tokyo, Japan

Expertise: Islet physiology, Diabetes mellitus type 1 and type 2, Beta Cell, Insulin resistance, Metabolic syndrome

Dr. Xu Ran

Institute for Neurodegenerative Diseases University of California, USA

Expertise: Medicinal Chemistry, Structure-Based Drug Design, Organic Synthesis, Protein-Protein Interactions, Cyclized Peptides.

Asiye Meric

Anadolu University, Turkey

Expertise: synthesis, analysis and analgesic activities of some imidazole derivatives

Prof. Giulio Tarro

D. Cotugno Hospital Infectious Diseases, Italy

Expertise: Human herpesviruses, Tumour antigens, Human cancer, Respiratory Syncytial Virus, Lung tumors, Epithelial adenocarcinomas.

Dr. Jae-Sung Kim

University of Florida, USA

Expertise: Liver physiology and pathology, Ischemic injury, Mitochondria, Autophagy, Aging

Dr. Katalin Prokai-Tatrai

UNT System College of Pharmacy Texas, USA

Expertise: medicinal chemistry-based drug design and delivery into the central nervous system using prodrug approaches; neuroprotection based on estrogens, GC/LC-MS-based bioanalytical assay development, mass spectrometry-based proteomics.

Dr. Alaa H. Salama

National Research Center, Egypt

Expertise: Pharmacy, Pharmaceutics, Pharmacology, recent advances in drug delivery, Nanotechnology, Biopharmaceutics

Prof. Radostina Alexandrova

IEMPAM-BAS, Bulgaria

Expertise: Experimental Morphology and Pathology, Cellular biology, molecular and cellular toxicology.

Dr. Sharad Sharma

MacroGenics. Inc, USA

Expertise: Pharmacokinetics, Preclinical, Clinical data

Dr. Chenling Xiong

University of California, USA

Expertise: Lung endothelial cell, Endothelial hyperpermeability, MLC phosphorylation, Myocardial infarction, Clinical phenotypic, Pharmacogenomics

Dr. Masashi Asai

Nagasaki University Japan, Japan

Expertise: Biochemistry, Pharmacology, Neuroscience, Drug development

Dr. Farid Menaa

California Innovations Corp USA

Expertise: Personalized Medicine, Preventive Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Internal Medicine, Oncology, Anti-Aging, OMICS, Stem Cells and Regenerative Medicine, Nanomedicine, Biotechnology, Nanotechnology

The exceptional editorial board members have been amassed for this summit. Every editorial board member was chosen in view of their individual specialized topic and capacity to convey right information.